Attached files
file | filename |
---|---|
EX-10.9 - FORM OF INTEC PHARMA LTD. 2015 EQUITY INCENTIVE PLAN NOTICE OF NON-QUALIFIED STO - Intec Pharma Ltd. | f10k2019ex10-9_intec.htm |
EX-32.2 - CERTIFICATION - Intec Pharma Ltd. | f10k2019ex32-2_intec.htm |
EX-32.1 - CERTIFICATION - Intec Pharma Ltd. | f10k2019ex32-1_intec.htm |
EX-31.2 - CERTIFICATION - Intec Pharma Ltd. | f10k2019ex31-2_intec.htm |
EX-31.1 - CERTIFICATION - Intec Pharma Ltd. | f10k2019ex31-1_intec.htm |
EX-10.8 - FORM OF INTEC PHARMA LTD. GRANT LETTER - SECTION 102 - Intec Pharma Ltd. | f10k2019ex10-8_intec.htm |
EX-4.4 - DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 - Intec Pharma Ltd. | f10k2019ex4-4_intec.htm |
10-K - ANNUAL REPORT - Intec Pharma Ltd. | f10k2019_intecpharmaltd.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-230016) and S-8 (No. 333-227027, No. 333-222217, No. 333-209700 and No. 333-212801) of Intec Pharma Ltd. of our report dated March 13, 2020 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman | |
March 13, 2020 | Certified Public Accountants (Isr.) | |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il